DSpace Repository

Structural Change in Microbiota by a Probiotic Cocktail Enhances the Gut Barrier and Reduces Cancer via TLR2 Signaling in a Rat Model of Colon Cancer

Show simple item record

dc.contributor.author Dogkotenge Kuugbee, Eugene
dc.contributor.author Shang, Xueqi
dc.contributor.author Gamallat, Yaser
dc.contributor.author Bamba, Djibril
dc.contributor.author Awadasseid, Annoor
dc.contributor.author Ahmed Suliman, Mohammed
dc.contributor.author Zang, Shizhu
dc.contributor.author Ma, Yufang
dc.contributor.author Chiwala, Gift
dc.contributor.author Xin, Yi
dc.contributor.author Shang, Dong
dc.date.accessioned 2016-12-21T19:21:38Z
dc.date.available 2016-12-21T19:21:38Z
dc.date.issued 2016-01-24
dc.identifier.citation https://www.ncbi.nlm.nih.gov/pubmed/27384052 en_US
dc.identifier.uri http://hdl.handle.net/123456789/86
dc.description Paper about Structural Change in Microbiota by a Probiotic Cocktail Enhances the Gut Barrier and Reduces Cancer via TLR2 Signaling in a Rat Model of Colon Cancer en_US
dc.description.abstract BACKGROUND: Structural change in the gut microbiota is implicated in cancer. The beneficial modulation of the microbiota composition with probiotics and prebiotics prevents diseases. AIM: We investigated the effect of oligofructose-maltodextrin-enriched Lactobacillus acidophilus, Bifidobacteria bifidum, and Bifidobacteria infantum (LBB), on the gut microbiota composition and progression of colorectal cancer. METHODS: Sprague Dawley rats were acclimatized, given ampicillin (75 mg/kg), and treated as follows; GCO: normal control; GPR: LBB only; GPC: LBB+ 1,2-dimethylhydrazine dihydrochloride (DMH); and GCA: DMH only (cancer control). 16S V4 Pyrosequencing for gut microbiota analysis, tumor studies, and the expression of MUC2, ZO-1, occludin, TLR2, TLR4, caspase 3, COX-2, and β-catenin were conducted at the end of experiment. RESULTS: Probiotic LBB treatment altered the gut microbiota. The relative abundance of genera Pseudomonas, Congregibacter, Clostridium, Candidactus spp., Phaeobacter, Escherichia, Helicobacter, and HTCC was decreased (P < 0.05), but the genus Lactobacillus increased (P < 0.05), in LBB treatment than in cancer control. The altered gut microbiota was associated with decreased tumor incidence (80 % in GPC vs. 100 % in GCA, P = 0.0001), tumor volume (GPC 84.23 (42.75-188.4) mm(3) vs. GCA 243 (175.5-344.5) mm(3), P < 0.0001) and tumor multiplicity/count (GPC 2.92 ± 0.26 vs. GCA 6.27 ± 0.41; P < 0.0001). The expression of MUC2, ZO-1, occludin, and TLR2 was increased, but expression of TLR4, caspase 3, Cox-2, and β-catenin was decreased by LBB treatment than in cancer control GCA (P < 0.05). CONCLUSION: Administration of LBB modulates the gut microbiota and reduces colon cancer development by decreasing tumor incidence, multiplicity/count, and volume via enhanced TLR2-improved gut mucosa epithelial barrier integrity and suppression of apoptosis and inflammation. en_US
dc.language.iso en en_US
dc.subject Colorectal cancer en_US
dc.subject Lactobacillus en_US
dc.subject Bifidobacteria en_US
dc.subject Probiotics en_US
dc.subject Microbiota en_US
dc.subject Toll-like en_US
dc.subject receptors (TLRs) en_US
dc.title Structural Change in Microbiota by a Probiotic Cocktail Enhances the Gut Barrier and Reduces Cancer via TLR2 Signaling in a Rat Model of Colon Cancer en_US
dc.type Working Paper en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account